Skip to main content

Israel Molina Romero

Sóc metge i responsable de la Unitat de Medicina Tropical i Salut Internacional

Institutions of which they are part

Head of group
Infectious Diseases
Vall Hebron Institut de Recerca
Infectious Diseases
General Hospital

Israel Molina Romero

Institutions of which they are part

Head of group
Infectious Diseases
Vall Hebron Institut de Recerca
Infectious Diseases
General Hospital

Sóc metge i responsable de la Unitat de Medicina Tropical i Salut Internacional

Llicenciat en Medicina per la UAB. Adjunt del Servei de Malalties Infeccioses Hospital Universitari Vall d'Hebron. Responsable de la Unitat de Medicina Tropical i Salut Internacional de l'Hospital Vall d'Hebron. Director del Programa de Salut Internacional de l'ICS. Experiència clínica i de recerca a Guinea Ecuatorial, Brasil i Angola.

Projects

Integración en el Servicio de Enfermedades Infecciosas

IP: Israel Molina Romero
Collaborators: Maria Luisa Aznar Ruiz de Alegria, Laia Perez Lasarte
Funding agency: Instituto de Salud Carlos III
Funding: 180000
Reference: JR21/00027
Duration: 26/05/2022 - 25/05/2026

Pesquisa operativa contra a desnutrição crônica infantil em Angola (Projeto CRESCER)

IP: Israel Molina Romero
Collaborators: Maria Luisa Aznar Ruiz de Alegria, Elena del Carmen Trigo Esteban, Bibiana Planas Ribas, Marta Sanchiz Cruz, Marc Molins Masdefiol, Esperanza Esteban Serna, Josep Roca Grande, Jose Cabral Jamba , Tayná Marques Torres Barboza
Funding agency: EUROPEAN COMMISSION
Funding: 3004510.89
Reference: CRESCER_EUROPEAID2019_
Duration: 15/02/2021 - 15/07/2026

Ferramentas inovadoras para a edUcação e o empoderamento de jovens em políTicas de Saúde SexUal e ReprOdutiva (FUTURO)

IP: Maria Luisa Aznar Ruiz de Alegria
Collaborators: Israel Molina Romero, Esperanza Esteban Serna
Funding agency: EUROPEAN COMMISSION
Funding: 454839.16
Reference: FUTURO_EUROPEAID2019
Duration: 03/11/2020 - 31/10/2024

Identificación de biomarcadores de miocardiopatía chagásica mediante el uso de la metabolómica

IP: Israel Molina Romero
Collaborators: Pau Bosch Nicolau, Nuria Serre Delcor
Funding agency: Instituto de Salud Carlos III
Funding: 68970
Reference: PI19/01807
Duration: 01/01/2020 - 31/12/2023

Related news

AIDAY 2026 showcased the artificial intelligence initiatives, infrastructures and projects already being developed across the Campus.

All patients showed a favorable clinical course and responded well to antibiotic treatment, without complications.

The study results show that the local presence of IL-1β promotes the development of myeloid cells with an immunosuppressive function.

Related professionals

Xavier Santamaria Costa

Xavier Santamaria Costa

Postdoctoral researcher
Biomedical Research in Gynaecology
Read more
Meritxell Ibernon Vilaró

Meritxell Ibernon Vilaró

Kidney Physiopathology
Read more
Marian Del Hoyo Martín

Marian Del Hoyo Martín

Research technician
Psychiatry, Mental Health and Addictions
Read more
Laura Castillo Ribelles

Laura Castillo Ribelles

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.